These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2902130)

  • 61. Effect of active and passive immunization on the development of experimental Pseudomonas aeruginosa pyelonephritis in mice.
    Petit JC; Sicard D; Bayo S; Daguet GL
    Can J Microbiol; 1981 Jan; 27(1):93-7. PubMed ID: 6783287
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The efficacy of combination immunotherapy in experimental Pseudomonas sepsis.
    Cross AS; Opal SM; Palardy JE; Bodmer MW; Sadoff JC
    J Infect Dis; 1993 Jan; 167(1):112-8. PubMed ID: 8418157
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Prevention using a Pseudomonas immunoglobulin in burn patients].
    Stuttmann R; Petrovici V; Hartert M
    Infection; 1987; 15(1):80-4. PubMed ID: 3106234
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
    Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
    J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice.
    O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S
    Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined pre-immunization and granulocyte transfusion therapy for treatment of pseudomonas septicemia in neutropenic dogs.
    Harvath L; Andersen BR; Zander AR; Epstein RB
    J Lab Clin Med; 1976 May; 87(5):840-7. PubMed ID: 1270891
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of the (Fab')2 fragment of the anti-Pseudomonas aeruginosa antibodies on Pseudomonas-induced keratitis in rats].
    Ren PX
    Yan Ke Xue Bao; 1986 Dec; 2(4):255-7. PubMed ID: 3147914
    [No Abstract]   [Full Text] [Related]  

  • 69. Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.
    Shime N; Sawa T; Fujimoto J; Faure K; Allmond LR; Karaca T; Swanson BL; Spack EG; Wiener-Kronish JP
    J Immunol; 2001 Nov; 167(10):5880-6. PubMed ID: 11698464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models.
    Yang F; Gu J; Yang L; Gao C; Jing H; Wang Y; Zeng H; Zou Q; Lv F; Zhang J
    Sci Rep; 2017 Jun; 7(1):3957. PubMed ID: 28638106
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immune globulin intravenous replacement after plasma exchange.
    Dau PC
    J Clin Apher; 1983; 1(2):104-8. PubMed ID: 6681480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.
    Hill HR; Bathras JM
    Rev Infect Dis; 1986; 8 Suppl 4():S396-400. PubMed ID: 3092306
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R; Sharma A; Wu W; Sung B; Worgall S
    Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The concomitant effect of a gamma-globulin preparation with an antibiotic on experimental Pseudomonas aeruginosa infections in mice].
    Shigeno Y; Sawatari K; Watanabe K; Tanaka H; Tomonaga A; Kohno S; Suzuyama Y; Yamaguchi K; Saito A; Hara K
    Kansenshogaku Zasshi; 1983 Jun; 57(6):531-6. PubMed ID: 6443738
    [No Abstract]   [Full Text] [Related]  

  • 77. Pseudomonas immune globulin therapy improves survival in experimental Pseudomonas aeruginosa bacteremic pneumonia.
    Collins MS; Edwards A; Roby RE; Mehton NS; Ladehoff D
    Antibiot Chemother (1971); 1989; 42():184-92. PubMed ID: 2596836
    [No Abstract]   [Full Text] [Related]  

  • 78. New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.
    Hammarström L; Smith CI
    Infection; 1990; 18(5):314-24. PubMed ID: 2125980
    [No Abstract]   [Full Text] [Related]  

  • 79. Recent experience with Pseudomonas aeruginosa immune globulin for the treatment of experimental pneumonia.
    Pennington JE
    J Hosp Infect; 1988 Aug; 12 Suppl D():55-60. PubMed ID: 2902130
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE; Pier GB
    Infection; 1987; 15(1):56-9. PubMed ID: 3106230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.